Odense University Hospital is the largest and most specialized hospital in Southern Denmark. OUH is both Odense's and Funen's largest single workplace. It has a budget of 835 million Euro and has 11.000 employees.

There are 1,038 beds in Department of Oncology, Odense University Hospital.

During the past decade, Department of Oncology, Odense University Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Oncology, Odense University Hospital" #1 sponsor was "Odense University Hospital" with 6 trials, followed by "Per Pfeiffer" with 3 trials sponsored, "Danish Breast Cancer Cooperative Group" with 2 trials sponsored, "University of Southern Denmark" with 2 trials sponsored and "Christina Ruhlmann" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Odense University Hospital" #1 collaborator was "Odense University Hospital" with 5 trials as a collaborator, "Aarhus University Hospital" with 4 trials as a collaborator, "Aalborg University Hospital" with 2 trials as a collaborator, "Helsinn Healthcare SA" with 2 trials as a collaborator and "Rigshospitalet, Denmark" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Odense University Hospital" are "Metastatic Colorectal Cancer" (2 trials), "NSCLC" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Adverse Event" (1 trials) and "Bowel Problems" (1 trials). Many other conditions were trialed in "Department of Oncology, Odense University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Odense University Hospital" are "Drug" (15 trials), "Other" (3 trials), "Radiation" (3 trials), "Behavioral" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "60 Gy/30F" (1 trials), "66 Gy/33F" (1 trials), "Akynzeo" (1 trials), "Bevacizumab" (1 trials) and "CT-scans extended" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Odense University Hospital" are 14 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Oncology, Odense University Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Department of Oncology, Odense University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Odense University Hospital, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".